OmniAb
approved and clinical stage partner pipeline as of three products active antibodies | OmniAb
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
22 of 22
Similar slides by OmniAb
See diffirences between slides (animation)
Investor Presentation
August 2023
approved under regulatory review and clinical stage partner pipeline | OmniAb
Results
August 2023
approved under regulatory review and clinical stage partner pipeline | OmniAb
Investor Presentation
May 2023
approved and clinical stage partner pipeline as of three products active antibodies | OmniAb
Results
May 2023
approved and clinical stage partner pipeline as of three products active antibodies | OmniAb
Related slides by other companies
BenevolentAI
Investor Presentation
September 2024
cant existing value and future value growth potential significant | BenevolentAI
Dare Bioscience
Investor Presentation
February 2023
dare and dare dare i | Dare Bioscience
DiaCarta
SPAC
October 2022
strong product pipeline | DiaCarta
Talabat
Investor Presentation
September 2024
glossary | Delivery Hero
Other recent decks by OmniAb
See all presentations (10 decks)
Results
November 2024
Results
March 2024
Results
August 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights